These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28588073)

  • 1. Brd4-Brd2 isoform switching coordinates pluripotent exit and Smad2-dependent lineage specification.
    Fernandez-Alonso R; Davidson L; Hukelmann J; Zengerle M; Prescott AR; Lamond A; Ciulli A; Sapkota GP; Findlay GM
    EMBO Rep; 2017 Jul; 18(7):1108-1122. PubMed ID: 28588073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BET proteins are essential for the specification and maintenance of the epiblast lineage in mouse preimplantation embryos.
    Tsume-Kajioka M; Kimura-Yoshida C; Mochida K; Ueda Y; Matsuo I
    BMC Biol; 2022 Mar; 20(1):64. PubMed ID: 35264162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SMAD2/3 interactome reveals that TGFβ controls m
    Bertero A; Brown S; Madrigal P; Osnato A; Ortmann D; Yiangou L; Kadiwala J; Hubner NC; de Los Mozos IR; Sadée C; Lenaerts AS; Nakanoh S; Grandy R; Farnell E; Ule J; Stunnenberg HG; Mendjan S; Vallier L
    Nature; 2018 Mar; 555(7695):256-259. PubMed ID: 29489750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets.
    Situ Y; Liang Q; Zeng Z; Chen J; Shao Z; Xu Q; Lu X; Cui Y; Zhang J; Lu L; Deng L
    Front Endocrinol (Lausanne); 2023; 14():1089531. PubMed ID: 36793283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGFβ signalling is required to maintain pluripotency of human naïve pluripotent stem cells.
    Osnato A; Brown S; Krueger C; Andrews S; Collier AJ; Nakanoh S; Quiroga Londoño M; Wesley BT; Muraro D; Brumm AS; Niakan KK; Vallier L; Ortmann D; Rugg-Gunn PJ
    Elife; 2021 Aug; 10():. PubMed ID: 34463252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whsc1 links pluripotency exit with mesendoderm specification.
    Tian TV; Di Stefano B; Stik G; Vila-Casadesús M; Sardina JL; Vidal E; Dasti A; Segura-Morales C; De Andrés-Aguayo L; Gómez A; Goldmann J; Jaenisch R; Graf T
    Nat Cell Biol; 2019 Jul; 21(7):824-834. PubMed ID: 31235934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad2 is essential for maintenance of the human and mouse primed pluripotent stem cell state.
    Sakaki-Yumoto M; Liu J; Ramalho-Santos M; Yoshida N; Derynck R
    J Biol Chem; 2013 Jun; 288(25):18546-60. PubMed ID: 23649632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative structure-function analysis of bromodomain and extraterminal motif (BET) proteins in a gene-complementation system.
    Werner MT; Wang H; Hamagami N; Hsu SC; Yano JA; Stonestrom AJ; Behera V; Zong Y; Mackay JP; Blobel GA
    J Biol Chem; 2020 Feb; 295(7):1898-1914. PubMed ID: 31792058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation.
    Cheung KL; Zhang F; Jaganathan A; Sharma R; Zhang Q; Konuma T; Shen T; Lee JY; Ren C; Chen CH; Lu G; Olson MR; Zhang W; Kaplan MH; Littman DR; Walsh MJ; Xiong H; Zeng L; Zhou MM
    Mol Cell; 2017 Mar; 65(6):1068-1080.e5. PubMed ID: 28262505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erk5 Is a Key Regulator of Naive-Primed Transition and Embryonic Stem Cell Identity.
    Williams CA; Fernandez-Alonso R; Wang J; Toth R; Gray NS; Findlay GM
    Cell Rep; 2016 Aug; 16(7):1820-8. PubMed ID: 27498864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pluripotency transcription factors and Tet1/2 maintain Brd4-independent stem cell identity.
    Finley LWS; Vardhana SA; Carey BW; Alonso-Curbelo D; Koche R; Chen Y; Wen D; King B; Radler MR; Rafii S; Lowe SW; Allis CD; Thompson CB
    Nat Cell Biol; 2018 May; 20(5):565-574. PubMed ID: 29662175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activin/Nodal signalling maintains pluripotency by controlling Nanog expression.
    Vallier L; Mendjan S; Brown S; Chng Z; Teo A; Smithers LE; Trotter MW; Cho CH; Martinez A; Rugg-Gunn P; Brons G; Pedersen RA
    Development; 2009 Apr; 136(8):1339-49. PubMed ID: 19279133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switch enhancers interpret TGF-β and Hippo signaling to control cell fate in human embryonic stem cells.
    Beyer TA; Weiss A; Khomchuk Y; Huang K; Ogunjimi AA; Varelas X; Wrana JL
    Cell Rep; 2013 Dec; 5(6):1611-24. PubMed ID: 24332857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of embryonic stem cell identity by BRD4-dependent transcriptional elongation of super-enhancer-associated pluripotency genes.
    Di Micco R; Fontanals-Cirera B; Low V; Ntziachristos P; Yuen SK; Lovell CD; Dolgalev I; Yonekubo Y; Zhang G; Rusinova E; Gerona-Navarro G; Cañamero M; Ohlmeyer M; Aifantis I; Zhou MM; Tsirigos A; Hernando E
    Cell Rep; 2014 Oct; 9(1):234-247. PubMed ID: 25263550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanog requires BRD4 to maintain murine embryonic stem cell pluripotency and is suppressed by bromodomain inhibitor JQ1 together with Lefty1.
    Horne GA; Stewart HJ; Dickson J; Knapp S; Ramsahoye B; Chevassut T
    Stem Cells Dev; 2015 Apr; 24(7):879-91. PubMed ID: 25393219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BET bromodomain proteins are required for glioblastoma cell proliferation.
    Pastori C; Daniel M; Penas C; Volmar CH; Johnstone AL; Brothers SP; Graham RM; Allen B; Sarkaria JN; Komotar RJ; Wahlestedt C; Ayad NG
    Epigenetics; 2014 Apr; 9(4):611-20. PubMed ID: 24496381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graded Nodal/Activin signaling titrates conversion of quantitative phospho-Smad2 levels into qualitative embryonic stem cell fate decisions.
    Lee KL; Lim SK; Orlov YL; Yit le Y; Yang H; Ang LT; Poellinger L; Lim B
    PLoS Genet; 2011 Jun; 7(6):e1002130. PubMed ID: 21731500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel nodal enhancer dependent on pluripotency factors and smad2/3 signaling conditions a regulatory switch during epiblast maturation.
    Papanayotou C; Benhaddou A; Camus A; Perea-Gomez A; Jouneau A; Mezger V; Langa F; Ott S; Sabéran-Djoneidi D; Collignon J
    PLoS Biol; 2014 Jun; 12(6):e1001890. PubMed ID: 24960041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genome-wide CRISPR screen identifies BRD4 as a regulator of cardiomyocyte differentiation.
    Padmanabhan A; de Soysa TY; Pelonero A; Sapp V; Shah PP; Wang Q; Li L; Lee CY; Sadagopan N; Nishino T; Ye L; Yang R; Karnay A; Poleshko A; Bolar N; Linares-Saldana R; Ranade SS; Alexanian M; Morton SU; Jain M; Haldar SM; Srivastava D; Jain R
    Nat Cardiovasc Res; 2024 Mar; 3(3):317-331. PubMed ID: 39196112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyar-Mediated Recruitment of Brd2 to the Chromatin Attenuates Nanog Downregulation Following Induction of Differentiation.
    Luna-Peláez N; García-Domínguez M
    J Mol Biol; 2018 Apr; 430(8):1084-1097. PubMed ID: 29505757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.